Article feature image

ImmunoPrecise Antibodies Ltd. (IPA) CEO Jennifer Bath on Q1 2022 Results – Earnings Call Transcript

Stock Analysis

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2022 Earnings Conference Call September 9, 2021 4:30 PM ET
Company Participants
John Mullaly – Investor Relations
Jennifer Bath – President and Chief Executive Officer
Lisa Helbling – Chief Financial Officer
…

Click here to view the original article.

Tags:
,
Facebook Google+ Twitter Pinterest

Related Posts